Knowledge

Progressive pseudorheumatoid dysplasia

Source đź“ť

151: 107: 194:
PPD is an extremely rare disease. In the United States the disease is estimated to affect less than 5,000 people and approximately 1 per million people in the United Kingdom however it is believed to be more common in Turkey and the Middle East.
142:
Treatment for PPD is supportive. Anti-inflammatory drugs may be used for pain due to secondary osteoarthritis. More severe joint pain may be treated with surgery. Physical therapy, occupational therapy, may help with joint stiffness.
46:
gene, which encodes a signalling factor involved in cartilage homeostasis. Genomic changes to the gene result in a non-functional protein, which disrupts cartilage aintenance and bone growth. The disorder is inherited in an
351:
Bhavani, Gandham SriLakshmi; Shah, Hitesh; Shukla, Anju; Dalal, Ashwin; Girisha, Katta Mohan (1993), Adam, Margaret P.; Everman, David B.; Mirzaa, Ghayda M.; Pagon, Roberta A. (eds.),
22:(PPD, PPRD), also known as progressive pseudorheumatoid arthropathy of childhood (PPAD), is a disorder of bone and cartilage that affects many joints. The disorder leads to 264:
Torreggiani, Sofia; Torcoletti, Marta; Campos-Xavier, Belinda; Baldo, Francesco; Agostoni, Carlo; Superti-Furga, Andrea; Filocamo, Giovanni (March 2019).
39: 162: 118: 240: 324: 212: 385:"Progressive pseudorheumatoid dysplasia with new-found gene mutation of Wntl inducible signaling pathway protein 3" 99:
Since symptoms of PPD are similar to juvenile rhematoid arthritis, people with PPD may be initially misdiagnosed.
241:"Progressive pseudorheumatoid dysplasia - About the Disease - Genetic and Rare Diseases Information Center" 383:
Chen, Wenji; Mo, Shiyan; Luo, Gui; Wang, Yanyan; Deng, Xiaohu; Zhu, Jian; Zhao, Wei (2018-09-10).
448: 453: 8: 48: 419: 384: 301: 30:
and widening of the ends of the finger and toe bones as well as other tubular bones.
424: 406: 360: 293: 285: 305: 414: 396: 277: 93: 352: 401: 281: 442: 410: 289: 27: 265: 428: 364: 297: 23: 150: 106: 263: 266:"Progressive pseudorheumatoid dysplasia: a rare childhood disease" 59:
Symptoms are present typically between ages three and six years.
96:
or through radiography with characteristic skeletal features.
325:"Progressive pseudorheumatoid dysplasia: MedlinePlus Genetics" 350: 359:, Seattle (WA): University of Washington, Seattle, 440: 69:Stiffness in the joints of the fingers and knees 40:Wnt1-inducible signalling protein 3 (WISP3) gene 217:NORD (National Organization for Rare Disorders) 382: 73:Symptoms that may develop over time include: 418: 400: 353:"Progressive Pseudorheumatoid Dysplasia" 213:"Progressive pseudorheumatoid dysplasia" 186:PPD has no severe effect on life span. 20:Progressive pseudorheumatoid disyplasia 441: 346: 344: 319: 317: 315: 235: 233: 145: 101: 13: 14: 465: 341: 312: 230: 149: 105: 38:PPD is caused by changes in the 189: 80:enlarged finger and knee joints 376: 257: 205: 92:PPD is diagnosed by molecular 1: 198: 181: 137: 87: 7: 54: 16:Bone and cartilage disorder 10: 470: 270:Rheumatology International 402:10.1186/s12969-018-0272-7 282:10.1007/s00296-018-4170-6 245:rarediseases.info.nih.gov 77:permanently bent fingers 63:Abnormal walking pattern 33: 389:Pediatric Rheumatology 42:, also known as the 49:autosomal recessive 161:. You can help by 117:. You can help by 179: 178: 135: 134: 461: 433: 432: 422: 404: 380: 374: 373: 372: 371: 348: 339: 338: 336: 335: 321: 310: 309: 261: 255: 254: 252: 251: 237: 228: 227: 225: 224: 209: 174: 171: 153: 146: 130: 127: 109: 102: 66:Weakness/fatigue 469: 468: 464: 463: 462: 460: 459: 458: 439: 438: 437: 436: 381: 377: 369: 367: 349: 342: 333: 331: 329:medlineplus.gov 323: 322: 313: 262: 258: 249: 247: 239: 238: 231: 222: 220: 211: 210: 206: 201: 192: 184: 175: 169: 166: 159:needs expansion 140: 131: 125: 122: 115:needs expansion 94:genetic testing 90: 57: 36: 17: 12: 11: 5: 467: 457: 456: 451: 435: 434: 375: 340: 311: 276:(3): 441–452. 256: 229: 219:. 16 June 2022 203: 202: 200: 197: 191: 188: 183: 180: 177: 176: 170:September 2022 156: 154: 139: 136: 133: 132: 126:September 2022 112: 110: 89: 86: 85: 84: 81: 78: 71: 70: 67: 64: 56: 53: 35: 32: 15: 9: 6: 4: 3: 2: 466: 455: 452: 450: 449:Rare diseases 447: 446: 444: 430: 426: 421: 416: 412: 408: 403: 398: 394: 390: 386: 379: 366: 362: 358: 354: 347: 345: 330: 326: 320: 318: 316: 307: 303: 299: 295: 291: 287: 283: 279: 275: 271: 267: 260: 246: 242: 236: 234: 218: 214: 208: 204: 196: 187: 173: 164: 160: 157:This section 155: 152: 148: 147: 144: 129: 120: 116: 113:This section 111: 108: 104: 103: 100: 97: 95: 82: 79: 76: 75: 74: 68: 65: 62: 61: 60: 52: 50: 45: 41: 31: 29: 28:short stature 25: 21: 454:Osteopathies 392: 388: 378: 368:, retrieved 357:GeneReviews® 356: 332:. Retrieved 328: 273: 269: 259: 248:. Retrieved 244: 221:. Retrieved 216: 207: 193: 190:Epidemiology 185: 167: 163:adding to it 158: 141: 123: 119:adding to it 114: 98: 91: 72: 58: 43: 37: 24:stiff joints 19: 18: 51:pattern. 443:Categories 370:2022-09-07 334:2022-09-07 250:2022-09-07 223:2022-09-07 199:References 411:1546-0096 395:(1): 55. 290:1437-160X 182:Prognosis 138:Treatment 88:Diagnosis 429:30200995 365:26610319 306:53528751 298:30327864 83:hip pain 55:Symptoms 420:6131911 427:  417:  409:  363:  304:  296:  288:  302:S2CID 34:Cause 425:PMID 407:ISSN 361:PMID 294:PMID 286:ISSN 44:CCN6 415:PMC 397:doi 278:doi 165:. 121:. 445:: 423:. 413:. 405:. 393:16 391:. 387:. 355:, 343:^ 327:. 314:^ 300:. 292:. 284:. 274:39 272:. 268:. 243:. 232:^ 215:. 26:, 431:. 399:: 337:. 308:. 280:: 253:. 226:. 172:) 168:( 128:) 124:(

Index

stiff joints
short stature
Wnt1-inducible signalling protein 3 (WISP3) gene
autosomal recessive
genetic testing

adding to it

adding to it
"Progressive pseudorheumatoid dysplasia"


"Progressive pseudorheumatoid dysplasia - About the Disease - Genetic and Rare Diseases Information Center"
"Progressive pseudorheumatoid dysplasia: a rare childhood disease"
doi
10.1007/s00296-018-4170-6
ISSN
1437-160X
PMID
30327864
S2CID
53528751



"Progressive pseudorheumatoid dysplasia: MedlinePlus Genetics"


"Progressive Pseudorheumatoid Dysplasia"
PMID

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑